Science Abstracts
RELATED CONTENT
NEWS
- Acura investors euphoric over US FDA OK of oxycodone painkiller
- Comparative efficacy should have a "formal role in drug licensing"
- Wall Street smiles on first US autologous aesthetic cell therapy approval
- Positive Phase III data for LifeCycle's 'improved Prograf' despite higher drop-out

